Don't get left behind! The modernized is coming. Check it out now.
Say goodbye to!
The new site is coming soon - go to the modernized
Working… Menu

The PUMA Trial is a Trial of a Single ProHema Modulated-Cord Blood (CB) Unit as Part of a Double CB Transplant in Patients With Hematologic Malignancies.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01627314
Recruitment Status : Terminated (Business decision)
First Posted : June 25, 2012
Last Update Posted : November 30, 2021
Information provided by (Responsible Party):
Fate Therapeutics

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : March 2016
Actual Study Completion Date : May 2017
Certification/Extension First Submitted : November 24, 2021